Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study

Patients with narcolepsy often experience disturbed nighttime sleep. Modafinil is commonly prescribed for hypersomnolence, but its impacts on nocturnal sleep remain unclear. This study uses actigraphy to examine the effect of modafinil on both hypersomnolence and nocturnal sleep patterns in patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sleep medicine 2024-07, Vol.119, p.95-102
Hauptverfasser: Chin, Wei-Chih, Huang, Yu-Shu, Trevor Lam, Ngo Yan, Mak, Ka Yu, Tang, I., Wang, Chih-Huan, Lin, Chen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 102
container_issue
container_start_page 95
container_title Sleep medicine
container_volume 119
creator Chin, Wei-Chih
Huang, Yu-Shu
Trevor Lam, Ngo Yan
Mak, Ka Yu
Tang, I.
Wang, Chih-Huan
Lin, Chen
description Patients with narcolepsy often experience disturbed nighttime sleep. Modafinil is commonly prescribed for hypersomnolence, but its impacts on nocturnal sleep remain unclear. This study uses actigraphy to examine the effect of modafinil on both hypersomnolence and nocturnal sleep patterns in patients with narcolepsy. Prior to treatment, 87 patients with narcolepsy wore an actigraphy for 7–14 days to assess their nighttime sleep. After evaluation, they received a daily dose of 200–400 mg of modafinil in the morning and wore an actigraphy again six months after initiating treatment. Questionnaires, including the Epworth-Sleepiness-Scale (ESS), the Visual-Analogue-for-Hypersomnolence (VAS), and the Short-Form-36-Health-Survey (SF-36), were used to evaluate hypersomnolence and quality of life both before and after treatment. Paired t-tests and independent samples t-tests were used for pre- and post-treatment comparisons and subgroup analysis. We used the Pearson's correlation test to measure the correlations between the sleep parameters of the actigraphy and data of the questionnaires. Improvements in hypersomnolence were noted following modafinil treatment, and we observed no significant deterioration in nocturnal sleep parameters by the actigraphy. The total number of awakenings by actigraphy significantly decreased (p = 0.005), especially in females (p = 0.008), while sleep onset latency significantly increased in children/adolescents (p = 0.014). Correlations were found between the sleep parameters of the actigraphy and ESS, VAS, and SF-36 scores. Modafinil treatment may not worsen nighttime sleep in patients with narcolepsy. However, it should be administered with care in children and adolescents. •Narcolepsy patients often experience disturbed nighttime sleep, but the impacts of modafinil on their sleep remain unclear.•This study uses subjective measurements and actigraphy to examine the effect of modafinil on hypersomnolence and sleep.•No significant deterioration in actigraphic parameters was observed, along with significantly decreased number of awakenings.•Modafinil may not worsen sleep in narcolepsy patients, but should be administered with care in children and adolescents.
doi_str_mv 10.1016/j.sleep.2024.04.024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3047952572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1389945724001928</els_id><sourcerecordid>3047952572</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-c3428aa27311cc0db930b75b1faaa31cf6a1211edee00252b785749add63c0d03</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMoWj9-gSA5emnNx-5mV_BQxC8oeNGbELLJLKZskzXJKv33prZ6FIaZObzvvMyD0DklM0podbWcxR5gmDHCihnJxYo9NKG1qKdlSar9vPO6mTZFKY7QcYxLQqigdXGIjnhdVU3Nqwl6u-s60Cli3-GVN6qzzvbYO-y8TmNwqsc_KXhQKUFwEVu32S24bPqy6R07FbTvYYjrazzH2r_7kHBMo1mfooNO9RHOdvMEvd7fvdw-ThfPD0-388VUc9Kk3AtWK8UEp1RrYtqGk1aULe2UUpzqrlKUUQoGgBBWslbUpSgaZUzFs5zwE3S5vTsE_zFCTHJlo4a-Vw78GCUnhWhKVgqWpXwr1cHHGKCTQ7ArFdaSErnBKpfy52G5wSpJLlZk18UuYGxXYP48vxyz4GYrgPzmp4Ugo86INBgbMl5pvP034BuMXosQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3047952572</pqid></control><display><type>article</type><title>Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Chin, Wei-Chih ; Huang, Yu-Shu ; Trevor Lam, Ngo Yan ; Mak, Ka Yu ; Tang, I. ; Wang, Chih-Huan ; Lin, Chen</creator><creatorcontrib>Chin, Wei-Chih ; Huang, Yu-Shu ; Trevor Lam, Ngo Yan ; Mak, Ka Yu ; Tang, I. ; Wang, Chih-Huan ; Lin, Chen</creatorcontrib><description>Patients with narcolepsy often experience disturbed nighttime sleep. Modafinil is commonly prescribed for hypersomnolence, but its impacts on nocturnal sleep remain unclear. This study uses actigraphy to examine the effect of modafinil on both hypersomnolence and nocturnal sleep patterns in patients with narcolepsy. Prior to treatment, 87 patients with narcolepsy wore an actigraphy for 7–14 days to assess their nighttime sleep. After evaluation, they received a daily dose of 200–400 mg of modafinil in the morning and wore an actigraphy again six months after initiating treatment. Questionnaires, including the Epworth-Sleepiness-Scale (ESS), the Visual-Analogue-for-Hypersomnolence (VAS), and the Short-Form-36-Health-Survey (SF-36), were used to evaluate hypersomnolence and quality of life both before and after treatment. Paired t-tests and independent samples t-tests were used for pre- and post-treatment comparisons and subgroup analysis. We used the Pearson's correlation test to measure the correlations between the sleep parameters of the actigraphy and data of the questionnaires. Improvements in hypersomnolence were noted following modafinil treatment, and we observed no significant deterioration in nocturnal sleep parameters by the actigraphy. The total number of awakenings by actigraphy significantly decreased (p = 0.005), especially in females (p = 0.008), while sleep onset latency significantly increased in children/adolescents (p = 0.014). Correlations were found between the sleep parameters of the actigraphy and ESS, VAS, and SF-36 scores. Modafinil treatment may not worsen nighttime sleep in patients with narcolepsy. However, it should be administered with care in children and adolescents. •Narcolepsy patients often experience disturbed nighttime sleep, but the impacts of modafinil on their sleep remain unclear.•This study uses subjective measurements and actigraphy to examine the effect of modafinil on hypersomnolence and sleep.•No significant deterioration in actigraphic parameters was observed, along with significantly decreased number of awakenings.•Modafinil may not worsen sleep in narcolepsy patients, but should be administered with care in children and adolescents.</description><identifier>ISSN: 1389-9457</identifier><identifier>EISSN: 1878-5506</identifier><identifier>DOI: 10.1016/j.sleep.2024.04.024</identifier><identifier>PMID: 38669836</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Actigraphy ; Adolescent ; Adult ; Benzhydryl Compounds - pharmacology ; Benzhydryl Compounds - therapeutic use ; Central Nervous System Stimulants - pharmacology ; Central Nervous System Stimulants - therapeutic use ; Child ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Modafinil ; Modafinil - pharmacology ; Modafinil - therapeutic use ; Narcolepsy ; Narcolepsy - drug therapy ; Nighttime awakening ; Quality of Life ; Sleep - drug effects ; Sleep disturbance ; Surveys and Questionnaires ; Treatment Outcome ; Wakefulness-Promoting Agents - pharmacology ; Wakefulness-Promoting Agents - therapeutic use ; Young Adult</subject><ispartof>Sleep medicine, 2024-07, Vol.119, p.95-102</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c309t-c3428aa27311cc0db930b75b1faaa31cf6a1211edee00252b785749add63c0d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1389945724001928$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38669836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chin, Wei-Chih</creatorcontrib><creatorcontrib>Huang, Yu-Shu</creatorcontrib><creatorcontrib>Trevor Lam, Ngo Yan</creatorcontrib><creatorcontrib>Mak, Ka Yu</creatorcontrib><creatorcontrib>Tang, I.</creatorcontrib><creatorcontrib>Wang, Chih-Huan</creatorcontrib><creatorcontrib>Lin, Chen</creatorcontrib><title>Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study</title><title>Sleep medicine</title><addtitle>Sleep Med</addtitle><description>Patients with narcolepsy often experience disturbed nighttime sleep. Modafinil is commonly prescribed for hypersomnolence, but its impacts on nocturnal sleep remain unclear. This study uses actigraphy to examine the effect of modafinil on both hypersomnolence and nocturnal sleep patterns in patients with narcolepsy. Prior to treatment, 87 patients with narcolepsy wore an actigraphy for 7–14 days to assess their nighttime sleep. After evaluation, they received a daily dose of 200–400 mg of modafinil in the morning and wore an actigraphy again six months after initiating treatment. Questionnaires, including the Epworth-Sleepiness-Scale (ESS), the Visual-Analogue-for-Hypersomnolence (VAS), and the Short-Form-36-Health-Survey (SF-36), were used to evaluate hypersomnolence and quality of life both before and after treatment. Paired t-tests and independent samples t-tests were used for pre- and post-treatment comparisons and subgroup analysis. We used the Pearson's correlation test to measure the correlations between the sleep parameters of the actigraphy and data of the questionnaires. Improvements in hypersomnolence were noted following modafinil treatment, and we observed no significant deterioration in nocturnal sleep parameters by the actigraphy. The total number of awakenings by actigraphy significantly decreased (p = 0.005), especially in females (p = 0.008), while sleep onset latency significantly increased in children/adolescents (p = 0.014). Correlations were found between the sleep parameters of the actigraphy and ESS, VAS, and SF-36 scores. Modafinil treatment may not worsen nighttime sleep in patients with narcolepsy. However, it should be administered with care in children and adolescents. •Narcolepsy patients often experience disturbed nighttime sleep, but the impacts of modafinil on their sleep remain unclear.•This study uses subjective measurements and actigraphy to examine the effect of modafinil on hypersomnolence and sleep.•No significant deterioration in actigraphic parameters was observed, along with significantly decreased number of awakenings.•Modafinil may not worsen sleep in narcolepsy patients, but should be administered with care in children and adolescents.</description><subject>Actigraphy</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Benzhydryl Compounds - pharmacology</subject><subject>Benzhydryl Compounds - therapeutic use</subject><subject>Central Nervous System Stimulants - pharmacology</subject><subject>Central Nervous System Stimulants - therapeutic use</subject><subject>Child</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Modafinil</subject><subject>Modafinil - pharmacology</subject><subject>Modafinil - therapeutic use</subject><subject>Narcolepsy</subject><subject>Narcolepsy - drug therapy</subject><subject>Nighttime awakening</subject><subject>Quality of Life</subject><subject>Sleep - drug effects</subject><subject>Sleep disturbance</subject><subject>Surveys and Questionnaires</subject><subject>Treatment Outcome</subject><subject>Wakefulness-Promoting Agents - pharmacology</subject><subject>Wakefulness-Promoting Agents - therapeutic use</subject><subject>Young Adult</subject><issn>1389-9457</issn><issn>1878-5506</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMoWj9-gSA5emnNx-5mV_BQxC8oeNGbELLJLKZskzXJKv33prZ6FIaZObzvvMyD0DklM0podbWcxR5gmDHCihnJxYo9NKG1qKdlSar9vPO6mTZFKY7QcYxLQqigdXGIjnhdVU3Nqwl6u-s60Cli3-GVN6qzzvbYO-y8TmNwqsc_KXhQKUFwEVu32S24bPqy6R07FbTvYYjrazzH2r_7kHBMo1mfooNO9RHOdvMEvd7fvdw-ThfPD0-388VUc9Kk3AtWK8UEp1RrYtqGk1aULe2UUpzqrlKUUQoGgBBWslbUpSgaZUzFs5zwE3S5vTsE_zFCTHJlo4a-Vw78GCUnhWhKVgqWpXwr1cHHGKCTQ7ArFdaSErnBKpfy52G5wSpJLlZk18UuYGxXYP48vxyz4GYrgPzmp4Ugo86INBgbMl5pvP034BuMXosQ</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Chin, Wei-Chih</creator><creator>Huang, Yu-Shu</creator><creator>Trevor Lam, Ngo Yan</creator><creator>Mak, Ka Yu</creator><creator>Tang, I.</creator><creator>Wang, Chih-Huan</creator><creator>Lin, Chen</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202407</creationdate><title>Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study</title><author>Chin, Wei-Chih ; Huang, Yu-Shu ; Trevor Lam, Ngo Yan ; Mak, Ka Yu ; Tang, I. ; Wang, Chih-Huan ; Lin, Chen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-c3428aa27311cc0db930b75b1faaa31cf6a1211edee00252b785749add63c0d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Actigraphy</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Benzhydryl Compounds - pharmacology</topic><topic>Benzhydryl Compounds - therapeutic use</topic><topic>Central Nervous System Stimulants - pharmacology</topic><topic>Central Nervous System Stimulants - therapeutic use</topic><topic>Child</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Modafinil</topic><topic>Modafinil - pharmacology</topic><topic>Modafinil - therapeutic use</topic><topic>Narcolepsy</topic><topic>Narcolepsy - drug therapy</topic><topic>Nighttime awakening</topic><topic>Quality of Life</topic><topic>Sleep - drug effects</topic><topic>Sleep disturbance</topic><topic>Surveys and Questionnaires</topic><topic>Treatment Outcome</topic><topic>Wakefulness-Promoting Agents - pharmacology</topic><topic>Wakefulness-Promoting Agents - therapeutic use</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chin, Wei-Chih</creatorcontrib><creatorcontrib>Huang, Yu-Shu</creatorcontrib><creatorcontrib>Trevor Lam, Ngo Yan</creatorcontrib><creatorcontrib>Mak, Ka Yu</creatorcontrib><creatorcontrib>Tang, I.</creatorcontrib><creatorcontrib>Wang, Chih-Huan</creatorcontrib><creatorcontrib>Lin, Chen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Sleep medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chin, Wei-Chih</au><au>Huang, Yu-Shu</au><au>Trevor Lam, Ngo Yan</au><au>Mak, Ka Yu</au><au>Tang, I.</au><au>Wang, Chih-Huan</au><au>Lin, Chen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study</atitle><jtitle>Sleep medicine</jtitle><addtitle>Sleep Med</addtitle><date>2024-07</date><risdate>2024</risdate><volume>119</volume><spage>95</spage><epage>102</epage><pages>95-102</pages><issn>1389-9457</issn><eissn>1878-5506</eissn><abstract>Patients with narcolepsy often experience disturbed nighttime sleep. Modafinil is commonly prescribed for hypersomnolence, but its impacts on nocturnal sleep remain unclear. This study uses actigraphy to examine the effect of modafinil on both hypersomnolence and nocturnal sleep patterns in patients with narcolepsy. Prior to treatment, 87 patients with narcolepsy wore an actigraphy for 7–14 days to assess their nighttime sleep. After evaluation, they received a daily dose of 200–400 mg of modafinil in the morning and wore an actigraphy again six months after initiating treatment. Questionnaires, including the Epworth-Sleepiness-Scale (ESS), the Visual-Analogue-for-Hypersomnolence (VAS), and the Short-Form-36-Health-Survey (SF-36), were used to evaluate hypersomnolence and quality of life both before and after treatment. Paired t-tests and independent samples t-tests were used for pre- and post-treatment comparisons and subgroup analysis. We used the Pearson's correlation test to measure the correlations between the sleep parameters of the actigraphy and data of the questionnaires. Improvements in hypersomnolence were noted following modafinil treatment, and we observed no significant deterioration in nocturnal sleep parameters by the actigraphy. The total number of awakenings by actigraphy significantly decreased (p = 0.005), especially in females (p = 0.008), while sleep onset latency significantly increased in children/adolescents (p = 0.014). Correlations were found between the sleep parameters of the actigraphy and ESS, VAS, and SF-36 scores. Modafinil treatment may not worsen nighttime sleep in patients with narcolepsy. However, it should be administered with care in children and adolescents. •Narcolepsy patients often experience disturbed nighttime sleep, but the impacts of modafinil on their sleep remain unclear.•This study uses subjective measurements and actigraphy to examine the effect of modafinil on hypersomnolence and sleep.•No significant deterioration in actigraphic parameters was observed, along with significantly decreased number of awakenings.•Modafinil may not worsen sleep in narcolepsy patients, but should be administered with care in children and adolescents.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38669836</pmid><doi>10.1016/j.sleep.2024.04.024</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1389-9457
ispartof Sleep medicine, 2024-07, Vol.119, p.95-102
issn 1389-9457
1878-5506
language eng
recordid cdi_proquest_miscellaneous_3047952572
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Actigraphy
Adolescent
Adult
Benzhydryl Compounds - pharmacology
Benzhydryl Compounds - therapeutic use
Central Nervous System Stimulants - pharmacology
Central Nervous System Stimulants - therapeutic use
Child
Cohort Studies
Female
Humans
Male
Middle Aged
Modafinil
Modafinil - pharmacology
Modafinil - therapeutic use
Narcolepsy
Narcolepsy - drug therapy
Nighttime awakening
Quality of Life
Sleep - drug effects
Sleep disturbance
Surveys and Questionnaires
Treatment Outcome
Wakefulness-Promoting Agents - pharmacology
Wakefulness-Promoting Agents - therapeutic use
Young Adult
title Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T19%3A06%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20modafinil%20on%20nocturnal%20sleep%20patterns%20in%20patients%20with%20narcolepsy:%20A%20cohort%20study&rft.jtitle=Sleep%20medicine&rft.au=Chin,%20Wei-Chih&rft.date=2024-07&rft.volume=119&rft.spage=95&rft.epage=102&rft.pages=95-102&rft.issn=1389-9457&rft.eissn=1878-5506&rft_id=info:doi/10.1016/j.sleep.2024.04.024&rft_dat=%3Cproquest_cross%3E3047952572%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3047952572&rft_id=info:pmid/38669836&rft_els_id=S1389945724001928&rfr_iscdi=true